发明名称 Therapy program modification
摘要 A therapy program may be modified based on information indicative of a change in a therapy field, which may represent a region of a patient's tissue to which therapy is delivered. Upon receiving information indicative of a therapy field change, an algorithmic model of a present therapy field may be generated and compared to an algorithmic model of a baseline therapy field, which indicates a therapy field that provides efficacious therapy to the patient. If a characteristic of the present therapy field differs from the baseline therapy field model, the current therapy program may be modified. In another example, upon receiving information indicative of a therapy field change, the current therapy program may be modified, and an algorithmic model of a therapy field based on the modified therapy program may be compared to a baseline therapy field model to determine whether the modified therapy program is a suitable alternative.
申请公布号 US8958870(B2) 申请公布日期 2015.02.17
申请号 US200912989740 申请日期 2009.01.23
申请人 Medtronic, Inc. 发明人 Gerber Martin T.;Rondoni John C.
分类号 A61N1/37;A61N1/372;A61N1/36 主分类号 A61N1/37
代理机构 Shumaker & Sieffert, P.A. 代理人 Shumaker & Sieffert, P.A.
主权项 1. A method comprising: receiving, with one or more processors, information indicative of a change in a first therapy field, wherein the first therapy field was generated by prior delivery of therapy, by a medical device, to tissue of a patient according to a therapy program, wherein prior to the change in the first therapy field, when the medical device delivers therapy according to the therapy program, the first therapy field is generated, and wherein the change in the first therapy field occurs without change to the therapy program; in response to receiving the information indicative of the change in the first therapy field, generating, with the one or more processors, a first therapy field model based on the therapy program that is used to generate the first therapy field prior to the change in the first therapy field and the information indicative of the change in the first therapy field; comparing, with the one or more processors, the first therapy field model to an algorithmic model of a baseline therapy field; and modifying, with the one or more processors, the therapy program based on the comparison of the first therapy field model to the algorithmic model of the baseline therapy field.
地址 Minneapolis MN US